The company will make a primary infusion of Rs 45 crore with an eventual acquisition of the remaining 9.5 per cent of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback